z-logo
Premium
Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hr after tracer injection in sentinel lymph node biopsy in breast cancer patients
Author(s) -
Edwina Doting M.H.,
Annemiek Stiekema H.M.,
de Vries Jakob,
Lemstra Clara,
Hoekstra Harald J.,
Vrieling Mirjam,
Rietman Lianne,
Jager Pieter L.
Publication year - 2006
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.20721
Subject(s) - medicine , lymph , sentinel lymph node , breast cancer , biopsy , lymph node , sentinel node , radiology , axillary lymph nodes , scintigraphy , surgery , cancer , pathology
Objective Immediate dynamic imaging enables accurate definition of sentinel lymph nodes, whereas imaging 3 hr after tracer injection may lead to overestimation of the number of sentinel lymph nodes. A study was performed to define the value of lymphoscintigraphy immediately versus 3 hr after tracer injection in sentinel lymph node biopsy for breast cancer management. Methods In 165 sentinel lymph node biopsy procedures preoperative immediate and 3 hr post‐injection lymphoscintigraphy was performed after intraparenchymal tracer administration. Results Lymph node visualization occurred in 63 immediate procedures (38%) versus in 163 procedures 3 hr post‐injection (99%). In 17 procedures (10%) in which immediate lymphoscintigraphy had visualized sentinel lymph nodes, additional nodes had been seen on 3 hr post‐injection lymphoscintigraphy. In eight of these procedures (5%) all nodes were detected in the same draining lymph node basin. Non‐axillary sentinel lymph nodes were identified by preoperative lymphoscintigraphy in 28 procedures (17%) and improved staging in three patients (5%). Conclusion The only impact of immediate lymphoscintigraphy was the possible omission of removal of 1–2 sec‐echelon nodes per patient in 5% of patients. We consider this yield too low to continue immediate lymphoscintigraphy in breast cancer patients. J. Surg. Oncol. 2007;95:469–475. © 2006 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom